Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
OrigStone Biotech
Suzhou, Jiangsu, China
- Ownership
- Private
- Development stage
- Other
01
Overview
OrigStone Biotech is a biopharmaceutical company specializing in the discovery and development of next-generation targeted protein degradation (TPD) therapies. Headquartered in Suzhou, China, the company leverages its proprietary OrigStone-TPD platform to design small molecule degraders, including molecular glues and PROTACs, for traditionally "undruggable" targets. Their primary therapeutic focus is on oncology and immunology, with a pipeline centered on high-value targets like GSPT1 and the Ikaros protein family. Founded by industry veterans with significant experience in protein degradation, OrigStone aims to overcome the limitations of current therapies through innovative chemical biology and drug discovery techniques.
- Therapeutic areas
- OncologyImmunology
- Modalities
- Molecular glue therapySmall moleculeProteolysis-targeting chimera therapy
- Industry
- Biotech
Beyond the preview
Go deeper on OrigStone Biotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on OrigStone Biotech.